United States securities and exchange commission logo





                          March 10, 2021

       Eric Adams
       President and Chief Executive Officer
       InMed Pharmaceuticals Inc.
       Suite 310 - 815 W. Hastings Street, Vancouver, B.C.
       V6C 1B4
       Canada

                                                        Re: InMed
Pharmaceuticals Inc.
                                                            Registration
Statement on Form S-1
                                                            Filed March 5, 2021
                                                            File No. 333-253925

       Dear Mr. Adams:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Kasey
Robinson at 202-551-5880 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Daniel Miller